Medimetriks Pharmaceuticals Inc.
8 drugs in NADAC|4 Generic,4 Brand
Medimetriks Pharmaceuticals Inc. lists 8 NDCs in the CMS NADAC file (4 generic, 4 brand), at an average NADAC of $40.77 per unit, with a week-over-week move of +0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
8
4G / 4B
Avg Price / Unit
$40.7720
$0.23 – $289.83
Avg 7d Change
+0.73%
Across 4 drugs with changes
7d Activity
of 8 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
clindamycin phosphate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Corticosteroid therapeutic class
Review the broader class where Medimetriks Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Medimetriks Pharmaceuticals Inc. make?
Medimetriks Pharmaceuticals Inc. lists 8 NDCs in the CMS NADAC file — 4 generic and 4 brand products.
What is the average price of Medimetriks Pharmaceuticals Inc. drugs?
The average NADAC across Medimetriks Pharmaceuticals Inc.'s portfolio is $40.7720 per unit, ranging from $0.2331 to $289.8260.
What types of drugs does Medimetriks Pharmaceuticals Inc. make?
Medimetriks Pharmaceuticals Inc. makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (3), Lincosamide Antibacterial (3), Aminoglycoside Antibacterial (1), Azole Antifungal (1).
Has Medimetriks Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Medimetriks Pharmaceuticals Inc. in the openFDA feed.
How has Medimetriks Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 2 Medimetriks Pharmaceuticals Inc. products rose and 2 fell, with a portfolio-wide average change of +0.7%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CLINDACIN ETZ KIT clindamycin phosphate | $289.8260 per EA | — |
NEO-SYNALAR 0.5%-0.025% CREAM neomycin sulfate and fluocinolone acetonide | $13.2101 per GM | — |
CLINDACIN P 1% PLEDGETS clindamycin phosphate | $8.9433 per EA | — |
NEUAC GEL clindamycin phosphate and benzoyl peroxide | $6.9032 per GM | — |
KETODAN 2% FOAM ketoconazole | $3.4406 per GM | +5.02% |
CLINDACIN 1% FOAM clindamycin phosphate | $1.8305 per GM | -4.10% |
TOVET EMOLLIENT 0.05% FOAM CLOBETASOL PROPIONATE | $1.7892 per GM | -3.58% |
CLODAN 0.05% SHAMPOO clobetasol propionate | $0.2331 per ML | +5.56% |